Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
17.88
-1.27 (-6.63%)
Mar 13, 2026, 4:00 PM EDT - Market closed
Biodesix Stock Forecast
Stock Price Forecast
The 4 analysts that cover Biodesix stock have a consensus rating of "Strong Buy" and an average price target of $32.5, which forecasts a 81.77% increase in the stock price over the next year. The lowest target is $20 and the highest is $40.
Price Target: $32.5 (+81.77%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Biodesix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Feb 27, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +11.86% | Feb 17, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $30 → $20 | Strong Buy | Maintains | $30 → $20 | +11.86% | Sep 19, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $60 → $40 | Buy | Maintains | $60 → $40 | +123.71% | May 21, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $60 → $30 | Strong Buy | Maintains | $60 → $30 | +67.79% | May 14, 2025 |
Financial Forecast
Revenue This Year
109.16M
from 88.50M
Increased by 23.35%
Revenue Next Year
130.26M
from 109.16M
Increased by 19.33%
EPS This Year
-3.37
from -4.67
EPS Next Year
-1.57
from -3.37
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 114.5M | 137.1M | |
| Avg | 109.2M | 130.3M | |
| Low | 102.0M | 120.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 29.3% | 25.6% | |
| Avg | 23.3% | 19.3% | |
| Low | 15.3% | 10.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.64 | -1.17 | |
| Avg | -3.37 | -1.57 | |
| Low | -4.51 | -2.14 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.